Free U.S. shipping on orders over $125♥Shipped with tracking within 48 hours♥Pay by Zelle, Cash App or crypto♥Research use only♥Free U.S. shipping on orders over $125♥Shipped with tracking within 48 hours♥Pay by Zelle, Cash App or crypto♥Research use only♥Free U.S. shipping on orders over $125♥Shipped with tracking within 48 hours♥Pay by Zelle, Cash App or crypto♥Research use only♥

Registered VIP studies

This page lists ClinicalTrials.gov records that name VIP among their listed interventions. Titles, phases, and status are taken from the official registry. It is a research reference only. It is not medical advice, and it does not offer or recommend any product for human or veterinary use.

43Registered studies
3Recruiting
27Completed
7With results posted

43 of 4,477 registered studies · showing 1–25

Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).

TerminatedPhase 2VIP
NCT ID
NCT04433546
Sponsor
PhaseBio Pharmaceuticals Inc.
Registry dates
2020-07-15 – 2020-12-02
Enrollment
54 registered participants
Locations
United States
Conditions listed
Acute Respiratory Distress Syndrome; Coronavirus; Hypoxic Respiratory Failure; Hypoxemic Respiratory Failure +14 more